Dipexium Pharmaceuticals, LLC operates as a biopharmaceutical company that develops and commercializes, pexiganan, a small peptide anti-infective agent. It provides Locilex, a small peptide topical antibiotic for the treatment of mild and moderate skin infections in superficial wounds, including infected decubitus ulcers, infected burns, infected surgical wounds, and nasal colonization of methicillin-resistant staphylococcus aureus. The company was founded in 2010 and is based in White Plains, New York.
Address
SUITE 1905 61 BROADWAY
NEW YORK, NY 10006
United States
NEW YORK, NY 10006
United States
Key stats and ratios
| Q2 (Jun '14) | 2013 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | - | -146.02% |
| Return on average equity | - | -177.93% |
| Employees | 7 |
No comments:
Post a Comment